Beau Kilmer

Beau Kilmer, co-director of the RAND Drug Policy Research Center and an expert on drug policy, joins the conversation to discuss the future of psychedelics in the U.S. He delves into how societal attitudes toward substances like psilocybin and cannabis have shifted over time, often shaped by misinformation and cultural stigmas. Kilmer highlights the emerging therapeutic applications of psychedelics in mental health, reflecting on the challenges of regulatory hurdles and the importance of scientific research in changing perceptions.